At present, there is no vaccine against this virus still, researchers and experts are focusing on understanding the correlates of defensive immunity for fetus and information about few major components of maternal immune response required for prevention of transplacental transmission. This infection is majorly prevalent in the newborns in the United States. The progress of the ongoing COVID-19 pandemic, worldwide has substantially impact several healthcare domains and other areas of research activities. Research institutions are forced to take crucial precautions during the current lockdown status in several major economies. Though most research and manufacturing companies are facing shutdown positions and delays in most important tasks, few companies are continuing their studies and being active for vaccine research.
Major Key Players of the Cytomegalovirus (CMV) Vaccines Market are:Merck's, AlphaVax, Inc., and Moderna, Inc. are some companies working on CMV immunizations.
Read More @ https://www.openpr.com/news/2051339/cytomegalovirus-cmv-vaccines-market-is-set-to-experience
Major Key Players of the Cytomegalovirus (CMV) Vaccines Market are:Merck's, AlphaVax, Inc., and Moderna, Inc. are some companies working on CMV immunizations.
Read More @ https://www.openpr.com/news/2051339/cytomegalovirus-cmv-vaccines-market-is-set-to-experience
No comments:
Post a Comment